Trials / Completed
CompletedNCT04511507
CytoSorb in Patients With Liver Failure
Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Liver Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Institutul Clinic Fundeni · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hemoadsorption has been demonstrated to improve liver functional tests in patients with liver failure. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with acute liver failure, on liver functional tests, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | hemoadsorption | three consecutive sessions of hemoadsorption in patients with liver failure |
Timeline
- Start date
- 2016-02-10
- Primary completion
- 2021-08-30
- Completion
- 2021-08-30
- First posted
- 2020-08-13
- Last updated
- 2021-09-05
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04511507. Inclusion in this directory is not an endorsement.